| Heart failure in 2010. | |
| | |
MedLine Citation:
|
PMID: 20828344 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Heart Failure Congress 2010 in Berlin presented the latest trials and trends in the medical and mechanical therapy of heart failure in the presence of impaired or preserved left ventricular ejection fraction. It covered all aspects of heart failure from epidemiology through basic and translational science to prevention. The congress highlighted new drugs, novel biomarkers, updated trials, the role of imaging in risk stratification and the importance of telecare in the reduction of heart failure readmission. |
| | |
Authors:
|
Ayman El-Menyar; Wael AlMahmeed |
Related Documents
:
|
20350524 - Estimated glomerular filtration rate is an independent predictor for mortality of patie... 19350964 - The severe heart failure questionnaire: italian translation and linguistic validation. 16520254 - Relationships between clinical assessments and patients' perceptions of the effects of ... 15701474 - The impact of chronic heart failure on health-related quality of life data acquired in ... 7585814 - Immunohistochemical evaluation of the developing outflow tract in the rat: achieving ao... 19804104 - Myocardial ischemia and coronary microvascular vasomotion: the impact of hypercholester... |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Expert review of cardiovascular therapy Volume: 8 ISSN: 1744-8344 ISO Abbreviation: Expert Rev Cardiovasc Ther Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-10 Completed Date: 2010-12-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101182328 Medline TA: Expert Rev Cardiovasc Ther Country: England |
Other Details:
|
Languages: eng Pagination: 1231-4 Citation Subset: IM |
Affiliation:
|
Hamad General Hospital, Cardiology Department, PO Box 3050, Doha, Qatar. elmenyar@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Calcium Channel Blockers
/
therapeutic use Cardiac Myosins / physiology Cardiotonic Agents / therapeutic use Clinical Trials as Topic Enzyme Activators / therapeutic use Guanylate Cyclase / physiology Heart Failure / diagnosis*, physiopathology, therapy* Humans Prognosis Receptors, Vasopressin / antagonists & inhibitors Risk Assessment |
| Chemical | |
Reg. No./Substance:
|
0/Calcium Channel Blockers; 0/Cardiotonic Agents; 0/Enzyme Activators; 0/Receptors, Vasopressin; EC 3.6.1.-/Cardiac Myosins; EC 4.6.1.2/Guanylate Cyclase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clopidogrel in acute coronary syndrome: implications of recent study findings.
Next Document: Pleiotropic effects of statins in atherosclerotic disease.